Carl F. Nathan
Director/Board Member at Tres Cantos Open Lab Foundation
Network origin in Carl F. Nathan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Tres Cantos Open Lab Foundation
 Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK.
7
| Non-Profit Organization | Miscellaneous Commercial Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Carl F. Nathan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chief Executive Officer | |
| Brown University | College/University | Undergraduate Degree | |
| ABBOTT INDIA LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Imperial College London | College/University | Doctorate Degree | |
| University of Cambridge | College/University | Graduate Degree | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
| Knoll Pharmaceutical Co. | Chief Tech/Sci/R&D Officer | ||
| Hudson-Douglas Ltd. | President | ||
| AN2 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman |
Statistics
International
| United States | 9 |
| United Kingdom | 3 |
| Switzerland | 2 |
| India | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 5 |
| Finance | 2 |
Operational
| Director/Board Member | 11 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| President | 2 |
Most connected contacts
- Stock Market
- Insiders
- Carl F. Nathan
- Company connections
